AdaptHealth (AHCO) risk factors, FY2024 10-K

Risks Related to Our Business and Industry

1. 01Reliance on relatively few suppliers for the majority of AdaptHealth's patient service equipment and supplies could adversely affect its ability to operate
2. 02Supply chain disruptions and economy-wide labor shortages in the U.S. have negatively impacted, and may continue to negatively impact, AdaptHealth’s businesses
3. 03AdaptHealth has been negatively impacted by inflation and rising interest rates
4. 04AdaptHealth’s payor contracts are subject to renegotiation or termination, which could result in a decrease in AdaptHealth’s revenue or profits
5. 05Changes made by payors to the way they cover products supplied by AdaptHealth could have an adverse impact on AdaptHealth’s revenue and operations
6. 06Changes in governmental or private payor supply replenishment schedules could adversely affect AdaptHealth
7. 07If AdaptHealth fails to manage the complex and lengthy reimbursement process, its revenue, financial condition and results of operations could suffer
8. 08AdaptHealth generates a significant portion of its revenue from the provision of sleep therapy equipment and supplies to patients, and AdaptHealth’s success is therefore highly dependent on its ability to furnish these items
9. 09AdaptHealth may be adversely affected by consolidation among health insurers and other industry participants
10. 10AdaptHealth may be adversely affected if it is unable to maintain current levels of collectability, and the deterioration of the financial condition of AdaptHealth’s payors or disputes with third parties could have a significant negative impact on its financial condition and results of operations
11. 11If AdaptHealth is unable to maintain or develop relationships with patient referral sources, its growth and profitability could be adversely affected
12. 12AdaptHealth experiences competition from numerous other sleep therapy equipment, home respiratory, mobility equipment and diabetes medical devices and supplies providers, and this competition could adversely affect its revenues and its business
13. 13Changes in medical equipment technology and development of new treatments may cause AdaptHealth’s current equipment or services to become obsolete
14. 14The use or anticipated use of artificial intelligence (“AI”) technologies, including generative AI, by us or third parties, may increase or create new operational risks
15. 15AdaptHealth's ability to successfully operate its business is largely dependent upon the efforts of key personnel of AdaptHealth, including senior management, the loss of any of whom could negatively impact AdaptHealth's operations and financial results
16. 16AdaptHealth’s strategic growth plan, which historically involved the acquisition of other companies, may not succeed
17. 17AdaptHealth’s current insurance program is expensive to maintain and may expose it to unexpected costs and negatively affect its business, financial condition and results of operations, particularly if it incurs losses not covered by its insurance or if claims or losses differ from its estimates

Risks Related to Regulation

1. 18AdaptHealth’s revenue could be impacted by federal and state changes to reimbursement and other Medicaid and Medicare policies
2. 19While AdaptHealth cannot predict what Medicare payment rates or coverage determinations will be in effect in future years, changes to payment rates or benefit coverages may materially impact its financial condition and results of operations
3. 20AdaptHealth’s operations are subject to various state and federal fraud and abuse laws, including, without limitation, the federal Anti-Kickback Statute, the federal Stark Law and the federal False Claims Act. These laws may impact, among other things, AdaptHealth’s sales, marketing and education programs
4. 21Failure by AdaptHealth to successfully design, modify and implement technology-based and other process changes to maximize productivity and ensure compliance could ultimately have a significant negative impact on AdaptHealth’s financial condition, reputation and results of operations
5. 22If CMS requires prior authorization or implements changes in documentation necessary for AdaptHealth’s products, AdaptHealth’s revenue, financial condition and results of operations could be negatively impacted
6. 23Reimbursement claims are subject to audits by various governmental and private payor entities from time to time and such audits may negatively affect AdaptHealth’s revenue, financial condition and results of operations
7. 24Significant reimbursement reductions and/or exclusion from markets or product lines could adversely affect AdaptHealth
8. 25Failure by AdaptHealth to maintain required licenses and accreditation could impact its operations
9. 26Actual or perceived failures to comply with applicable data protection, privacy and security, and consumer protection laws, regulations, standards and other requirements could adversely affect AdaptHealth's business, results of operations and financial condition
10. 27AdaptHealth may be adversely affected by global climate change or by legal, regulatory or market responses to such change

Risks Related to Our Financial Condition

1. 28If AdaptHealth were required to write down all or part of its goodwill, its net earnings and net worth could be materially adversely affected
2. 29AdaptHealth may not be able to generate sufficient cash flow to cover required payments or comply with financial and operating covenants under its long-term debt and long-term operating leases
3. 30AdaptHealth may need additional capital to fund its operating subsidiaries and finance its growth, and AdaptHealth may not be able to obtain it on acceptable terms, or at all, which may limit its ability to grow
4. 31We will continue to incur significant expenses and administrative burdens as a result of being a public company, which could have a material adverse effect on AdaptHealth's business, financial condition and results of operations
5. 32AdaptHealth’s only significant asset is its ownership of AdaptHealth Holdings, and such ownership may not be sufficient to generate the funds necessary to meet its financial obligations or to pay any dividends on its Common Stock

Risks Related to Our Securities

1. 33We may not be able to effectively maintain controls and procedures required by Section 404 of the Sarbanes-Oxley Act that are applicable to us or remediate existing material weaknesses
2. 34Fluctuations in the price of AdaptHealth’s securities could contribute to the loss of all or part of your investment
3. 35AdaptHealth’s board of directors previously authorized a share repurchase program for up to $200.0 million of AdaptHealth’s Common Stock, which expired on December 31, 2023. As of December 31, 2023, $43.3 million was repurchased under the share repurchase program
4. 36Certain of AdaptHealth's principal stockholders have significant influence over us
5. 37Because AdaptHealth has no current plans to pay cash dividends on its Common Stock for the foreseeable future, you may not receive any return on investment unless you sell your Common Stock for a price greater than that which you paid for it
6. 38We are required to make payments under the Tax Receivable Agreement for certain tax benefits we may claim, and the amounts of such payments could be significant
7. 39In certain cases, payments under the Tax Receivable Agreement may be accelerated and/or significantly exceed the actual benefits, if any, we realize in respect of the tax attributes subject to the Tax Receivable Agreement
8. 40We will not be reimbursed for any payments made to TRA Holders under the Tax Receivable Agreement in the event that any tax benefits are disallowed
9. 41The interests of the TRA Holders in our business may conflict with the interests of our stockholders